Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition Ltd has informed BSE that it published a newspaper advertisement on March 10, 2026, in The Free Press Journal (English) and Navshakti (Marathi), in compliance with a SEBI circular dated January 30, 2026. The ad informs shareholders about a special one-year window (from February 2026 to February 2027) for re-lodging transfer requests of physical shares that were rejected, returned, or left unattended due to document deficiencies before April 1, 2019. The company also reported that no such re-lodgement requests were received from shareholders between July 2025 and January 2026, and the RTA MUFG Intime India Private Limited has filed the required report with SEBI.
This is a routine regulatory compliance filing with no direct impact on the company's financials or stock price. Shareholders holding physical share certificates that were previously rejected for transfer now have an additional year to re-submit their transfer requests with proper documentation.